Another sign of the resurgence of neuropsychiatry as a clinical discipline was evident at the recent International Neuropsychiatric Congress in Seville, Spain. Held Aug. 28 through 31 at the Alfonso XIII Hotel, the meeting was co-sponsored by the American Neuropsychiatric Association, the University of Illinois at Chicago and the University of Seville. The meeting brought together investigators from many countries including the United States, Canada, Japan, and the continents of South America, Australia and Europe. Topics discussed included frontal lobe syndromes, molecular biology of neuropsychiatric illnesses, neuroimaging, HIV and drug therapies in neuropsychiatric disorders.
Internationalism is an important dimension of the growth of neuropsychiatry.
The International Neuropsychiatric Congress provided a critical forum for exchanging information about these disorders, sharing experience with treatment of these syndromes and coordinating plans for disseminating information in neuropsychiatry. Rapid dispersal of new information relevant to neuropsychiatric care is an important agenda for the world neuropsychiatric community. A second international neuropsychiatric congress is under active consideration. Creation of an international neuropsychiatric home page on the World Wide Web is planned, and an increase in international activity by the American Neuropsychiatric Association is also being contemplated. Vascular Dementia Philip Gorelick, M.D., of Rush-Presbyterian St. Luke's Medical Center, Chicago, presented an update on vascular dementia.